Cabukusta Birol, Nettebrock Niclas T, Kol Matthijs, Hilderink Angelika, Tafesse Fikadu G, Holthuis Joost C M
Molecular Cell Biology Division, Faculty of Biology/Chemistry, University of Osnabrück, 49076 Osnabrück, Germany.
Oregon Health and Science University, Portland, OR 97239, U.S.A.
Biosci Rep. 2017 Jul 16;37(4). doi: 10.1042/BSR20170867. Print 2017 Aug 31.
Ceramides are essential precursors of sphingolipids with a dual role as mediators of apoptotic cell death. Previous work revealed that the ER-resident ceramide phosphoethanolamine (CPE) synthase SMSr/SAMD8 is a suppressor of ceramide-mediated apoptosis in cultured cells. Anti-apoptotic activity of SMSr requires a catalytically active enzyme but also relies on the enzyme's N-terminal sterile α-motif or SAM domain. Here, we demonstrate that SMSr itself is a target of the apoptotic machinery. Treatment of cells with staurosporine or the death receptor ligand FasL triggers caspase-mediated cleavage of SMSr at a conserved aspartate located downstream of the enzyme's SAM domain and upstream of its first membrane span. Taking advantage of reconstitution experiments with SMSr produced in a cell-free expression system, specific caspase-inhibitors and gene silencing approaches, we show that SMSr is a novel and specific substrate of caspase-6, a non-conventional effector caspase implicated in Huntington's and Alzheimer's diseases. Our findings underscore a role of SMSr as negative regulator of ceramide-induced cell death and, in view of a prominent expression of the enzyme in brain, raise questions regarding its potential involvement in neurodegenerative disorders.
神经酰胺是鞘脂的重要前体,具有作为凋亡细胞死亡介质的双重作用。先前的研究表明,内质网驻留的神经酰胺磷酸乙醇胺(CPE)合酶SMSr/SAMD8是培养细胞中神经酰胺介导的细胞凋亡的抑制因子。SMSr的抗凋亡活性需要一种具有催化活性的酶,但也依赖于该酶的N端无菌α基序或SAM结构域。在这里,我们证明SMSr本身就是凋亡机制的一个靶点。用星形孢菌素或死亡受体配体FasL处理细胞会触发半胱天冬酶介导的SMSr在该酶SAM结构域下游和第一个跨膜区上游的一个保守天冬氨酸处的切割。利用在无细胞表达系统中产生的SMSr进行的重组实验、特异性半胱天冬酶抑制剂和基因沉默方法,我们表明SMSr是半胱天冬酶-6的一种新型特异性底物,半胱天冬酶-6是一种与亨廷顿病和阿尔茨海默病有关的非传统效应半胱天冬酶。我们的研究结果强调了SMSr作为神经酰胺诱导的细胞死亡的负调节因子的作用,并且鉴于该酶在大脑中的显著表达,提出了关于其在神经退行性疾病中潜在参与情况的问题。